GLUTATHIONE METABOLISM DURING SKIN TUMOR PROMOTION
皮肤肿瘤促进过程中的谷胱甘肽代谢
基本信息
- 批准号:3179578
- 负责人:
- 金额:$ 8.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-07-01 至 1988-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
One of the earliest responses to 12-0-tetradecanoylphorbol-13-acetate (TPA)
may be the generation of reactive oxygen species. Therefore, antioxidants
with their capacity to terminate free radical chain reactions would be
expected to modify the tumor promotion process. Recent studies from our
laboratory indicate that TPA decreases rapidly the intracellular ratio of
reduced glutathione (GSH)/oxidized glutathione (GSSG) in epidermal cell
suspensions. Moreover, treatments with cysteine (Cys), GSH and
Alpha-tocopherol inhibit dramatically the induction of epidermal ornithine
decarboxylase (ODC) activity by TPA, one of the essential components of
mouse skin tumor promotion, as well as the incidence of skin tumors in the
initiation-promotion protocol. Our findings suggest that Cys and GSH might
inhibit TPA-induced ODC activity and the promotion of skin papillomas
through an increase in the intracellular ratio of GSH/GSSG. Since the
inhibitory effects of Cys on both the decrease in the ratio of GSH/GSSG and
the induction of ODC activity by TPA are greatly reduced by the inhibitors
of Gamma-glutamyl transpeptidase (Gamma-GT) and Gamma-glutamylcysteine
synthetase, we believe it is important to rigorously study the metabolism
of GSH, a natural antioxidant which inhibits chemical carcinogenesis,
during skin tumor promotion. First, we will study the effects of various
tumor promoters on GSH level, Gamma-GT and GSH peroxidase activities, and
O2 production in isolated epidermal cells. Second, because functional
interrelationships between sulfur-containing amino acids, selenium, vitamin
E, and GSH peroxidase have been postulated, we will determine if treatments
including GSH level-raising agents, selenoamino acids and Alpha-tocopherol
might increase the antioxidant GSH peroxidase protective system of the
cells and inhibit the oxidative challenge linked to skin tumor promotion.
Finally, we will determine the effectiveness of combined treatments with
GSH level-raising agents, selenium-containing compounds and
Alpha-tocopherol as modifiers of the effects of TPA on GSH metabolism,
stimulators of the GSH-dependent antioxidant protective system and
inhibitors of multistage skin tumor promotion. These studies should help
us to identify new inhibitors of skin carcinogenesis and in general should
provide a better understanding of the biochemistry of tumor promotion and
its regulation.
对12-0-tetradecanoylphorbol-13-acetate(TPA)的最早反应之一
可能是活性氧物质的产生。 因此,抗氧化剂
它们终止自由基链式反应的能力
有望改变肿瘤促进过程。 我们最近的研究
实验室表明TPA迅速降低细胞内
表皮细胞还原型谷胱甘肽(GSH)/氧化型谷胱甘肽(GSSG)
停职 此外,用半胱氨酸(Cys)、GSH和
α-生育酚显著抑制表皮鸟氨酸的诱导
脱羧酶(ODC)活性的TPA,其中一个重要组成部分,
小鼠皮肤肿瘤的促进作用,以及皮肤肿瘤的发病率
启动-促进协议。 我们的研究结果表明,半胱氨酸和谷胱甘肽可能
抑制TPA诱导的ODC活性和促进皮肤乳头状瘤
通过增加细胞内GSH/GSSG的比例。 以来
Cys对GSH/GSSG比值的降低和
TPA对ODC活性的诱导作用被抑制剂大大降低
γ-谷氨酰转肽酶(γ-GT)和γ-谷氨酰半胱氨酸
合成酶,我们认为严格研究代谢是很重要的
GSH是一种天然抗氧化剂,可抑制化学致癌作用,
在皮肤肿瘤促进过程中。 首先,我们将研究各种因素的影响。
肿瘤促进剂对GSH水平、γ-GT和GSH过氧化物酶活性的影响,以及
离体表皮细胞中的O2产生。 第二,因为功能
含硫氨基酸、硒、维生素
E和GSH过氧化物酶已经假定,我们将确定是否治疗
包括GSH水平提高剂、硒氨基酸和α-生育酚
可能会增加抗氧化剂谷胱甘肽过氧化物酶保护系统的
细胞和抑制与皮肤肿瘤促进有关的氧化挑战。
最后,我们将确定联合治疗的有效性,
GSH水平提高剂、含硒化合物和
α-生育酚作为TPA对GSH代谢影响的调节剂,
GSH依赖性抗氧化保护系统的刺激物,
多阶段皮肤肿瘤促进的抑制剂。 这些研究应该有助于
我们要确定新的抑制剂的皮肤致癌作用,一般应
更好地了解肿瘤促进的生物化学,
其规定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jean-Pierre H Perchellet其他文献
Jean-Pierre H Perchellet的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jean-Pierre H Perchellet', 18)}}的其他基金
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
三蝶烯类似物--新型双功能抗癌药物
- 批准号:
6157638 - 财政年份:2000
- 资助金额:
$ 8.08万 - 项目类别:
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
三蝶烯类似物--新型双功能抗癌药物
- 批准号:
6377959 - 财政年份:2000
- 资助金额:
$ 8.08万 - 项目类别:
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
三蝶烯类似物--新型双功能抗癌药物
- 批准号:
6633756 - 财政年份:2000
- 资助金额:
$ 8.08万 - 项目类别:
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
三蝶烯类似物--新型双功能抗癌药物
- 批准号:
6754506 - 财政年份:2000
- 资助金额:
$ 8.08万 - 项目类别:
TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS
三蝶烯类似物--新型双功能抗癌药物
- 批准号:
6514600 - 财政年份:2000
- 资助金额:
$ 8.08万 - 项目类别:
TUMOR PROMOTING EFFECTS OF OKADAIC ACID AND PALYTOXIN
大田酸和海藻毒素的促肿瘤作用
- 批准号:
2097462 - 财政年份:1992
- 资助金额:
$ 8.08万 - 项目类别:
TUMOR-PROMOTING EFFECTS OF OKADAIC ACID AND PALYTOXIN
大田酸和海藻毒素的促肿瘤作用
- 批准号:
3201029 - 财政年份:1992
- 资助金额:
$ 8.08万 - 项目类别:
TUMOR-PROMOTING EFFECTS OF OKADAIC ACID AND PALYTOXIN
大田酸和海藻毒素的促肿瘤作用
- 批准号:
3201030 - 财政年份:1992
- 资助金额:
$ 8.08万 - 项目类别:
GLUTATHIONE METABOLISM DURING SKIN TUMOR PROMOTION
皮肤肿瘤促进过程中的谷胱甘肽代谢
- 批准号:
3179579 - 财政年份:1985
- 资助金额:
$ 8.08万 - 项目类别:
GLUTATHIONE METABOLISM DURING SKIN TUMOR PROMOTION
皮肤肿瘤促进过程中的谷胱甘肽代谢
- 批准号:
3179575 - 财政年份:1985
- 资助金额:
$ 8.08万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 8.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 8.08万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 8.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 8.08万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 8.08万 - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 8.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 8.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 8.08万 - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 8.08万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 8.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)